Advancements in Cardiac Care Fuel Brugada Syndrome Market Growth,...

bir ses eklendi Other

2026-04-30 13:14:48 -

Advancements in Cardiac Care Fuel Brugada Syndrome Market Growth, Featuring Leaders Medtronic, Abbott Laboratories, and Boston Scientific

The global Brugada Syndrome market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.8 billion by the end of 2034, growing at a CAGR of 7.8% from 2024 to 2034. Market growth is driven by increasing awareness of rare cardiac disorders, advancements in diagnostic technologies, and rising adoption of implantable cardioverter defibrillators (ICDs) and genetic testing for early...

0 Yorumlar 0 hisse senetleri 79 Views 0 önizleme